Sai Jai
Member
- Joined
- 5 Jan 2015
- Messages
- 39,360
- Reaction score
- 26,262
New Delhi: In a shocking revelation, all-rounder Yusuf Pathan had failed a dope test during a domestic match last season. The member of the 2011 World Cup winning side has been suspended for the violation. A statement by BCCI testifies the same. The statement said, "Mr Yusuf Pathan has been suspended for a doping violation. Mr Pathan had inadvertently ingested a prohibited substance, which can be commonly found in cough syrups.
"Mr Pathan had provided a urine sample as part of the BCCI’s anti-doping testing program during a domestic T-20 competition on 16th March 2017 in New Delhi. His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances.
On 27th October 2017, Mr Pathan was charged with the commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti-Doping Rules (ADR) Article 2.1 and provisionally suspended pending determination of the charge. Mr Pathan responded to the charge by admitting the ADRV and asserting that it was caused by his ingestion of a medication containing Terbutaline that had been mistakenly given to him instead of the medication prescribed for him, which did not contain any prohibited substance.
The BCCI is satisfied with Mr Pathan’s explanation that he had taken Terbutaline inadvertently to treat an Upper Respiratory Tract Infection (URTI) and not as a performance-enhancing drug. Having considered all of the evidence and taken expert external advice, the BCCI has accepted Mr Pathan’s explanation of the cause of his ADRV, and on that basis has agreed that a period of ineligibility of five months should apply, together with the disqualification of certain results.
Yusuf Pathan Suspended by BCCI After Dope Violation; Says He Took Cough Syrup
"Mr Pathan had provided a urine sample as part of the BCCI’s anti-doping testing program during a domestic T-20 competition on 16th March 2017 in New Delhi. His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances.
On 27th October 2017, Mr Pathan was charged with the commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti-Doping Rules (ADR) Article 2.1 and provisionally suspended pending determination of the charge. Mr Pathan responded to the charge by admitting the ADRV and asserting that it was caused by his ingestion of a medication containing Terbutaline that had been mistakenly given to him instead of the medication prescribed for him, which did not contain any prohibited substance.
The BCCI is satisfied with Mr Pathan’s explanation that he had taken Terbutaline inadvertently to treat an Upper Respiratory Tract Infection (URTI) and not as a performance-enhancing drug. Having considered all of the evidence and taken expert external advice, the BCCI has accepted Mr Pathan’s explanation of the cause of his ADRV, and on that basis has agreed that a period of ineligibility of five months should apply, together with the disqualification of certain results.
Yusuf Pathan Suspended by BCCI After Dope Violation; Says He Took Cough Syrup
Last edited:
